Pre-pregnancy Body Mass Index and Third-Trimester Depressive Symptoms in a Healthy Privately Insured Sample

Stephanie A. Schuette; Michelle A. Kominiarek; Katherine L. Wisner; Suena H. Massey

doi:10.1055/s-0038-1625974

American Journal of Perinatology Reports, Table of Contents

CC-BY-NC-ND 4.0 · AJP Rep 2018; 08(01): e13-e17
DOI: 10.1055/s-0038-1625974

Original Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Pre-pregnancy Body Mass Index and Third-Trimester Depressive Symptoms in a Healthy Privately Insured Sample

Authors

Stephanie A. Schuette

¹Department of Psychology and Neuroscience, Duke University, Durham, North Carolina
Michelle A. Kominiarek

²Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Katherine L. Wisner

²Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois

³Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Suena H. Massey

³Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois

⁴Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Abstract

Objectives While being overweight (body mass index [BMI] >25) prior to pregnancy is linked to antenatal depression, whether weight is confounded by socioeconomic and/or medical risks is unclear.

Study Design We assessed 66 healthy privately insured pregnant women at M = 35.0 ± 3.3 weeks for symptoms of depression (Inventory for Depressive Symptoms—Self-Report (IDS-SR 30), lifetime history of depression and other psychiatric conditions (Mini International Neuropsychiatric Interview), and pre-pregnancy BMI derived from pre-pregnancy weight (by recall) and directly measured height. Pre-pregnancy overweight (BMI > 25) and antenatal depression (score of mild or greater [14] on the IDS-SR 30) were assessed using logistic regression, controlling for past major depressive disorder (MDD) and demographic factors showing significant between group differences.

Results Pre-pregnancy overweight (n = 17; 25.8%) was associated with an increased risk of third trimester depression, independent of past MDD and marital status (odds ratio = 7.47; 95% confidence interval [2.09–26.68]; B (standard error) = 2.010 [0.650]).

Conclusion Replication in a larger sample is suggested to confirm an independent effect of pregravid overweight on third trimester depression.

Keywords

oxytocin - overweight - pregnancy - postpartum depression

Full Text

References

References
1 Fisher SC, Kim SY, Sharma AJ, Rochat R, Morrow B. Is obesity still increasing among pregnant women? Prepregnancy obesity trends in 20 states, 2003-2009. Prev Med 2013; 56 (06) 372-378
2 Ramachenderan J, Bradford J, McLean M. Maternal obesity and pregnancy complications: a review. Aust N Z J Obstet Gynaecol 2008; 48 (03) 228-235
3 Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics 2003; 111 (5 Pt 2): 1152-1158
4 Olivarez SA, Ferres M, Antony K. , et al. Obstructive sleep apnea screening in pregnancy, perinatal outcomes, and impact of maternal obesity. Am J Perinatol 2011; 28 (08) 651-658
5 Bodnar LM, Wisner KL, Moses-Kolko E, Sit DK, Hanusa BH. Prepregnancy body mass index, gestational weight gain, and the likelihood of major depressive disorder during pregnancy. J Clin Psychiatry 2009; 70 (09) 1290-1296
6 Ashley JM, Harper BD, Arms-Chavez CJ, LoBello SG. Estimated prevalence of antenatal depression in the US population. Arch Women Ment Health 2016; 19 (02) 395-400
7 Gentile S. Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review. Neuroscience 2017; 342: 154-166
8 Molyneaux E, Poston L, Ashurst-Williams S, Howard LM. Pre-pregnancy obesity and mental disorders during pregnancy and postpartum: a systematic review and meta-analysis. Pregnancy Hypertens 2014; 4 (03) 236
9 Bombard JM, Dietz PM, Galavotti C. , et al. Chronic diseases and related risk factors among low-income mothers. Matern Child Health J 2012; 16 (01) 60-71
10 Lancaster CA, Gold KJ, Flynn HA, Yoo H, Marcus SM, Davis MM. Risk factors for depressive symptoms during pregnancy: a systematic review. Am J Obstet Gynecol 2010; 202 (01) 5-14
11 Skrundz M, Bolten M, Nast I, Hellhammer DH, Meinlschmidt G. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology 2011; 36 (09) 1886-1893
12 Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996; 26 (03) 477-486
13 Rush AJ, Blacker D. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Publishing; 2008
14 Brunoni AR, Benute GR, Fráguas R. , et al. The self-rated Inventory of Depressive Symptomatology for screening prenatal depression. Int J Gynaecol Obstet 2013; 121 (03) 243-246
15 Sheehan D, Janavs J, Knapp E, Sheehan M, Baker R. Mini-International Neuropsychiatric Interview Clinician Rated, Version 4.0. Tampa, FL: University of South Florida College of Medicine; 1992
16 Luppino FS, de Wit LM, Bouvy PF. , et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67 (03) 220-229
17 Molyneaux E, Pasupathy D, Kenny LC. , et al; SCOPE consortium. Socio-economic status influences the relationship between obesity and antenatal depression: data from a prospective cohort study. J Affect Disord 2016; 202: 124-127
18 Rich-Edwards JW, Kleinman K, Abrams A. , et al. Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice. J Epidemiol Community Health 2006; 60 (03) 221-227
19 Castanon N, Lasselin J, Capuron L. Neuropsychiatric comorbidity in obesity: role of inflammatory processes. Front Endocrinol (Lausanne) 2014; 5: 74
20 Molica F, Morel S, Kwak BR, Rohner-Jeanrenaud F, Steffens S. Adipokines at the crossroad between obesity and cardiovascular disease. Thromb Haemost 2015; 113 (03) 553-566
21 Quante M, Dietrich A, ElKhal A, Tullius SG. Obesity-related immune responses and their impact on surgical outcomes. Int J Obes 2015; 39 (06) 877-883
22 Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci 2017; 1391 (01) 20-34
23 Broussard JL, Van Cauter E. Disturbances of sleep and circadian rhythms: novel risk factors for obesity. Curr Opin Endocrinol Diabetes Obes 2016; 23 (05) 353-359
24 Weinberger N-A, Kersting A, Riedel-Heller SG, Luck-Sikorski C. Body dissatisfaction in individuals with obesity compared to normal-weight individuals: a systematic review and meta-analysis. Obes Facts 2016; 9 (06) 424-441
25 Mellor R, Chua SC, Boyce P. Antenatal depression: an artefact of sleep disturbance?. Arch Women Ment Health 2014; 17 (04) 291-302
26 LaGrotte C, Fernandez-Mendoza J, Calhoun SL, Liao D, Bixler EO, Vgontzas AN. The relative association of obstructive sleep apnea, obesity and excessive daytime sleepiness with incident depression: a longitudinal, population-based study. Int J Obes 2016; 40 (09) 1397-1404